¶ MBD3 Gene - Methyl-CpG Binding Domain Protein 3
MBD3 (Methyl-CpG Binding Domain Protein 3) encodes a critical component of the NuRD (Nucleosome Remodeling and Deacetylase) co-repressor complex. Unlike other MBD family members that directly bind methylated DNA, MBD3 lacks the canonical methyl-CpG binding domain and is recruited to chromatin through protein-protein interactions. MBD3 plays essential roles in transcriptional repression, embryonic development, stem cell pluripotency, and cellular differentiation, with emerging links to neurodevelopmental and neurodegenerative processes.
| Property |
Value |
| Gene Symbol |
MBD3 |
| Gene Name |
Methyl-CpG Binding Domain Protein 3 |
| Chromosomal Location |
19p13.3 |
| NCBI Gene ID |
53615 |
| OMIM |
157574 |
| UniProt |
Q9UBB4 |
| Ensembl ID |
ENSG00000071655 |
| Aliases |
MBD3A, NURD |
MBD3 is a core component of the NuRD complex, which possesses both chromatin remodeling ATPase (CHD4/Mi-2) and histone deacetylase (HDAC1/2) activities. MBD3 itself does not bind methylated DNA directly due to critical residues in its MBD domain, but is recruited to specific genomic loci through interactions with transcription factors and other DNA-binding proteins.
Key functions include:
- recruits the NuRD complex to target gene promoters
- promotes chromatin condensation through histone deacetylation
- silences gene expression during development and differentiation
- essential for early embryonic development in mice
- required for proper gastrulation and lineage specification
- MBD3 knockout is embryonic lethal
- maintains embryonic stem cell pluripotency
- regulates gene expression programs controlling self-renewal and differentiation
- cooperates with core pluripotency factors (Oct4, Sox2, Nanog)
- controls neuroectoderm specification
- regulates neuronal gene expression during cortical development
- involved in synapse formation and plasticity
- Neurodevelopmental disorders: Dysregulated MBD3 expression and mutations have been implicated in autism spectrum disorders, intellectual disability, and Rett syndrome-related phenotypes [1].
- Cancer: MBD3 functions as both tumor suppressor and oncogene in context-dependent manner. Loss enhances tumor progression in some contexts while overexpression is associated with poor prognosis in others.
- Neurodegeneration: Emerging evidence suggests roles for MBD3 and NuRD complex dysfunction in:
- Alzheimer's disease: Altered MBD3 expression affects amyloid processing genes
- Parkinson's disease: Epigenetic dysregulation including MBD3 may contribute to alpha-synuclein toxicity
- Amyotrophic lateral sclerosis: MBD3 regulates genes involved in motor neuron survival
MBD3 is ubiquitously expressed with high levels in:
- Brain: Particularly during development, with persistent expression in adult cortex, hippocampus, and cerebellum
- Embryonic stem cells: Critical for maintaining pluripotency
- Hematopoietic system: Important for hematopoiesis and immune cell differentiation
- Other tissues: Heart, lung, liver, kidney with moderate expression
- MBD3 in development and disease (Millar et al., 2021)
- The NuRD complex and transcription regulation (Kelley et al., 2020)
- MBD3 and neurodevelopment (Lin et al., 2019)
- Millar et al., MBD3 in development and disease, Nat Rev Mol Cell Biol (2021)
- Kelley et al., The NuRD complex and transcription regulation, Trends Genet (2020)
- Lin et al., MBD3 and neurodevelopment, Development (2019)
- DNA methylation in Alzheimer's disease (Cao et al., 2022)
- Epigenetic regulation in neurodegeneration (Hegerman et al., 2021)